Literature DB >> 33190740

Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis.

J J Feddema1, E Claassen2.   

Abstract

Viral respiratory infections (VRI) can act as triggers for acute asthma exacerbations and contribute significantly to asthma-related healthcare costs. Knowing the patterns of viruses amongst asthmatics can be useful in treating and preventing these exacerbations and help decrease the burden they impose on patients and healthcare systems. We aimed to quantify the viral prevalence in asthmatics presenting with exacerbations and identify influencing factors. A meta-analysis with a systematic search was conducted. Random-effect analysis was performed to quantify prevalence of viruses. A meta-regression was conducted to explain sources of heterogeneity and identify confounding factors. A VRI was detected in 52%-65% of the cases, and the detection rate was higher in children compared to adults. Rhinovirus was most often detected [51-71%], followed by respiratory syncytial virus [8-18%], influenza virus [7-15%], human parainfluenza virus [4-11%] and metapneumovirus virus [3-9%]. Meta-regression showed that the variables age and hemisphere contributed to the heterogeneity observed and were significantly associated with the detection of viruses in asthmatics. The climate variable reached significance for RSV and indicated a higher detection rate of viruses in asthmatics living in temperate compared to tropical regions. Besides age, geographic location and related variables significantly influence to what extent respiratory viruses are detected amongst asthmatics with exacerbations. Our results indicate that health authorities should adopt region- and population specific prevention and treatment strategies. Prevention and detection of viral respiratory infections in asthmatics could reduce asthma related disease burden and decrease antibiotic misuse.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute exacerbation; Asthma; Meta-analysis; Respiratory viruses

Mesh:

Year:  2020        PMID: 33190740     DOI: 10.1016/j.rmed.2020.106020

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

Review 1.  Exposomic determinants of immune-mediated diseases: Special focus on type 1 diabetes, celiac disease, asthma, and allergies: The HEDIMED project approach.

Authors:  Jutta E Laiho; Olli H Laitinen; Johannes Malkamäki; Leena Puustinen; Aki Sinkkonen; Juha Pärkkä; Heikki Hyöty
Journal:  Environ Epidemiol       Date:  2022-06-08

Review 2.  Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma.

Authors:  Chioma Enweasor; Cameron H Flayer; Angela Haczku
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 3.  Rhinovirus and Cell Death.

Authors:  Shannic-Le Kerr; Cynthia Mathew; Reena Ghildyal
Journal:  Viruses       Date:  2021-04-07       Impact factor: 5.048

4.  Rhinovirus-Induced Cytokine Alterations With Potential Implications in Asthma Exacerbations: A Systematic Review and Meta-Analysis.

Authors:  Kong Yen Liew; Sue Kie Koh; Suet Li Hooi; Matthew Kah Lup Ng; Hui-Yee Chee; Hanis Hazeera Harith; Daud Ahmad Israf; Chau Ling Tham
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

5.  Parainfluenza Bronchiolitis Mimicking Recurrent Lobar Pneumonia.

Authors:  Keshav Bhattar; Trupti Pandit; Ramesh Pandit
Journal:  Cureus       Date:  2022-07-13

6.  Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.

Authors:  Eduardo Garcia-Pachon; Lucia Zamora-Molina; Maria J Soler-Sempere; Carlos Baeza-Martinez; Justo Grau-Delgado; Vicente Canto-Reig; Antonio Ramon-Sanchez; Isabel Padilla-Navas; Montserrat Ruiz-Garcia; Nieves Gonzalo-Jimenez
Journal:  Respir Med       Date:  2020-07-04       Impact factor: 4.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.